$7.35
-0.14-1.87%
At Close: -
$7.35
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
TScan Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TScan Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics | -$0.51 | -$0.28 | — | — | $3.15M | $2.42M | — | — | 08/08/2024 | Get Alert |
TCRX | TScan Therapeutics | -$0.93 | -$0.25 | -$0.32 | -28.00% | $6.80M | $3.97M | $566.00K | -85.74% | 05/13/2024 | Get Alert |
TCRX | TScan Therapeutics | -$0.78 | -$0.29 | -$0.21 | 27.59% | $3.10M | $3.34M | $7.21M | 115.90% | 03/06/2024 | Get Alert |
TCRX | TScan Therapeutics | -$0.67 | -$0.45 | -$0.24 | 46.67% | $3.36M | $4.09M | $3.89M | -4.96% | 11/09/2023 | Get Alert |
TCRX | TScan Therapeutics | -$0.63 | -$0.78 | -$0.51 | 34.62% | $4.06M | $4.03M | $3.15M | -21.89% | 08/10/2023 | Get Alert |
TCRX | TScan Therapeutics | -$0.67 | -$0.74 | -$0.93 | -25.68% | $3.02M | $4.40M | $6.80M | 54.61% | 05/10/2023 | Get Alert |
TCRX | TScan Therapeutics | $0.38 | -$0.70 | -$0.78 | -11.43% | $2.85M | $3.82M | $3.10M | -18.95% | 03/08/2023 | Get Alert |
TCRX | TScan Therapeutics | -$0.80 | -$0.72 | -$0.67 | 6.94% | $2.41M | $3.70M | $3.36M | -9.11% | 11/09/2022 | Get Alert |
TCRX | TScan Therapeutics | -$7.69 | — | -$0.63 | — | $2.85M | — | $4.06M | — | 08/10/2022 | Get Alert |
TCRX | TScan Therapeutics | -$6.49 | — | -$0.67 | — | $2.03M | — | $3.02M | — | 05/09/2022 | Get Alert |
TCRX | TScan Therapeutics | — | — | $0.38 | — | — | — | $2.85M | — | 03/09/2022 | Get Alert |
TCRX | TScan Therapeutics | -$7.16 | — | -$0.80 | — | $290.00K | — | $2.41M | — | 11/10/2021 | Get Alert |
TCRX | TScan Therapeutics | -$6.18 | — | -$7.69 | — | — | — | $2.85M | — | 08/19/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $-0.32 | $-0.25 | -28.0 % |
Dec 2023 | 2024-03-06 | $-0.21 | $-0.29 | 27.6 % |
Sep 2023 | 2023-11-09 | $-0.24 | $-0.45 | 46.7 % |
Jun 2023 | 2023-08-10 | $-0.51 | $-0.78 | 34.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $566.00K | $3.97M | -85.7 % |
Dec 2023 | 2024-03-06 | $7.21M | $3.34M | 115.9 % |
Sep 2023 | 2023-11-09 | $3.89M | $4.09M | -4.96 % |
Jun 2023 | 2023-08-10 | $3.15M | $4.03M | -21.9 % |
TScan Therapeutics (TCRX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
The Actual EPS was $-0.32, which missed the estimate of $-0.25.
The Actual Revenue was $566K, which missed the estimate of $4M.
Browse earnings estimates, EPS, and revenue on all stocks.